Birdwatch Note
2023-03-06 02:13:10 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Genevant sublicensed the patents to BioNTech, who then entered into an agreement with Pfizer to develop a COVID-19 vaccine. (NIH) and Moderna entered into an agreement in 2019 to co-develop coronavirus vaccines. The Pentagon does not own any rights to COVID-19 vaccines. https://www.sec.gov/Archives/edgar/data/1776985/000119312519241112/d635330dex1017.htm https://www.nature.com/articles/s41587-021-00912-9 https://www.axios.com/2020/06/25/moderna-nih-coronavirus-vaccine-ownership-agreements
Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1632557264178491392
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1632564948692877313
- noteId - 1632564948692877313
- participantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
- noteAuthorParticipantId -
- createdAtMillis - 1678068790015
- tweetId - 1632557264178491392
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Genevant sublicensed the patents to BioNTech, who then entered into an agreement with Pfizer to develop a COVID-19 vaccine. (NIH) and Moderna entered into an agreement in 2019 to co-develop coronavirus vaccines. The Pentagon does not own any rights to COVID-19 vaccines. https://www.sec.gov/Archives/edgar/data/1776985/000119312519241112/d635330dex1017.htm https://www.nature.com/articles/s41587-021-00912-9 https://www.axios.com/2020/06/25/moderna-nih-coronavirus-vaccine-ownership-agreements
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-06 02:13:10 UTC (1678068790015) |
2023-03-06 11:39:02 UTC (1678102742717) |
CURRENTLY_RATED_HELPFUL | 2023-03-07 02:11:29 UTC (1678155089929) |
CURRENTLY_RATED_HELPFUL | 2023-03-06 11:39:02 UTC (1678102742717) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-03-06 17:14:43 -0600 | 0097C32B4C739467556C3096A0542B2301B756CE6A4C761A1A926FEC754C4F76 | Rating Details |
| 2023-03-08 14:25:05 -0600 | 0378F20DFECC73D3AD98390D25AA66E2BCCAAB4A22DEE65AB440D4CB6446B2E7 | Rating Details |
| 2023-03-06 13:56:13 -0600 | 08956573BB2DC88E23E98EE7F3B4E96E8DD83B6A4D0EBCA73CA0D23CA67550C1 | Rating Details |
| 2023-03-07 08:35:58 -0600 | 0D6FFFA47567E494501FE5FC105052EDE2F3A9242702B097AFB25E9B96EA6B3C | Rating Details |
| 2023-03-06 21:58:21 -0600 | 11F32524E7492B3FBAB85F0008281A46AB9F81976EE8C9FF8006495E075FFF9A | Rating Details |
| 2023-03-07 18:35:25 -0600 | 12C8722150E006F18A711B2A7EC7918E58C984F746F84504371CEFDE1C108207 | Rating Details |
| 2023-03-06 04:40:04 -0600 | 14C37A6C4708FABEB2C7C99F99151C8701DC48E6DBFBF2FFE6AFB8DF8C1CF95E | Rating Details |
| 2023-03-06 15:40:34 -0600 | 1D22EFC60D8544A8D816C40D9324C8632559F64CD48BAE400477086A7F73FB2D | Rating Details |
| 2023-03-07 08:06:58 -0600 | 227B72516F48209D4CD398BD566B39A53B64980200BCA4A4C749072F49AA8384 | Rating Details |
| 2023-03-07 13:24:44 -0600 | 241D1262253FC4A550D866686AAA0918CEA2A07B0F474D3B30541BC3E81A4273 | Rating Details |
| 2023-03-06 10:21:00 -0600 | 25D67BF2FE297FFD75875CD17DBEFBCC930FF69E45C148D17F49F3273DAC1AE5 | Rating Details |
| 2023-03-05 22:51:22 -0600 | 260C934E5D09B5D032BDB93ACA96AADB30137D14B29E49EFDE4EFDB4A5485F65 | Rating Details |
| 2023-03-06 13:43:33 -0600 | 27ED594B6E471372D18D675C415AF7BFA33D468633A967B66260A2215ADCD356 | Rating Details |
| 2023-03-06 13:19:38 -0600 | 2F003C8C097873FA015E96C0F79D539CBEBB96C83966AC8431F6F3B570A85C2F | Rating Details |
| 2023-03-06 09:10:09 -0600 | 34BC1E89C4723C2FD1C55D5F18AA5914BF41C2C20256EDDC887AAF53C41280D7 | Rating Details |
| 2023-03-05 21:55:23 -0600 | 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 | Rating Details |
| 2023-03-06 10:32:05 -0600 | 4860D963BBC3BC4037411DB6A544A0BFF056916B226C1E4DF95ECB52D34866A5 | Rating Details |
| 2023-03-06 06:23:37 -0600 | 4888DD03916E34BF1D5A26F1F086934F7B78BFC7C8B1D28BA8E6C239DE506FB3 | Rating Details |
| 2023-03-06 13:05:48 -0600 | 49BF18B9E9F151774AC1F839011F4B79DB5DB7A2BAB7AD0DAE752624D49E3B76 | Rating Details |
| 2023-03-06 07:38:33 -0600 | 568ADFB5739FF4CEDFA5C4E7FB0AD45429CC3493C13B015B42838188A73D82B5 | Rating Details |
| 2023-03-06 14:37:37 -0600 | 581127A5893895B2877515647693B4C3A8B73806C334F2D5511DB53C11E8766B | Rating Details |
| 2023-03-06 19:04:52 -0600 | 630C6F37981FA73775932A0D3E1B7C9FBC397B991D45BC947F3DF9B655923A57 | Rating Details |
| 2023-03-07 12:17:09 -0600 | 6ECCD339E02BF5A9FD5816F3C6A7F1A58A789D1EF9637AB9B33DBDB78131E27F | Rating Details |
| 2023-03-06 13:08:37 -0600 | 71C6DEB91C10C6553D04AB5A52809950F16F61701BF3126F67A039434CF04A2D | Rating Details |
| 2023-03-05 21:34:06 -0600 | 71EB268E7A8F69DFC819CAAE0A760DFD1B895A145E18F142043E0C9900DB4061 | Rating Details |
| 2023-03-05 21:17:52 -0600 | 7981A2C40D6150AF302C8AD7A987AA43203E1B7AD414C9BDAD30EB7DC45672CB | Rating Details |
| 2023-03-07 15:07:59 -0600 | 7D3A53A94C9B19801E5DD8755BDAE6DFC77979A980C9420576975EDCB2E910DA | Rating Details |
| 2023-03-06 13:30:07 -0600 | 7D4862C88C9C828164AE6FEE9C32CFE7BB6AD1145FC86D28BF18004C56B3F346 | Rating Details |
| 2023-03-05 20:56:42 -0600 | 83F8C9FBF04EDF7CE0402610D70596E31ACF4323833A5EAB7FFC83BF5104A1FC | Rating Details |
| 2023-03-06 20:43:29 -0600 | 8B79F415D803EB1A2646AA38F6518FF92C7DD15D35042F6C0731FDB857FFB05C | Rating Details |
| 2023-03-06 10:33:42 -0600 | 959C165EC37A9318F088F21ED4E7DEF09A8E4DC765A53F7F64C77595ADA32409 | Rating Details |
| 2023-03-06 14:27:48 -0600 | 99ED08FF34C32845FD77E718542AD9CE18499948892E978310E72F249E5AC6EA | Rating Details |
| 2023-03-05 21:10:34 -0600 | B5FEE1C7F02671E2466AE0184315222BE9F827034DA0D608839BE86F8B7D554A | Rating Details |
| 2023-03-06 15:23:09 -0600 | BD4E22C122F339503AE44190484BFE8CC6E7D8E5433FFF3889F903B033C87CE3 | Rating Details |
| 2023-03-06 11:34:23 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
| 2023-03-06 04:34:21 -0600 | CE2DE647C2D2D1EE3738900B91EB4094D8F06FEA3FCF4D00EFC4D49B276FEC24 | Rating Details |
| 2023-03-06 05:27:54 -0600 | D40C1B2807A8B8D098FF57660F3CD424C2E3E92050915ED298591D85F63943BD | Rating Details |
| 2023-03-06 13:03:58 -0600 | D81BC69647D9FB234A0FC709A28D421B6420DEEB51429E15880CABE83DB359E3 | Rating Details |
| 2023-03-06 04:28:16 -0600 | DC1B038605EB7B153771BACDFFE6C9D25363704191B3240E4AAC28B7E18C77A6 | Rating Details |
| 2023-03-06 12:55:26 -0600 | E61D34E3BD5B9C53CFB9BCEF5F491EA879D0078633D08858B260239EF152FA14 | Rating Details |
| 2023-03-06 08:08:56 -0600 | EE3DB1CD2E462B13094CCEE4CF263ECB48BF995E78761CFCDDA707C502DB61B2 | Rating Details |
| 2023-03-05 21:29:12 -0600 | EE848598DCEB775E05753C8F9E2E1AE83D325CB4435FD8358DDAE49CFFA026ED | Rating Details |
| 2023-03-06 07:28:15 -0600 | F1AD115595A4B744F066D4F2BDCD677E57108251AB950D6A8DCE9C7814CF6D8C | Rating Details |
| 2023-03-06 13:08:38 -0600 | F1ADB7BEAE2FE0C347AE6A14C025FEB578A84E6F8AE92C03BDD100F004ACCCEA | Rating Details |
| 2023-03-06 05:21:20 -0600 | F33BDF32942A2853DDF851573ADE6062561A463354751D7C959E85A8D3752E4F | Rating Details |
| 2023-03-06 14:28:26 -0600 | FC4D8892A6AB6D47F8D46D765F40BBB7E5D8C08432DDC2CDA49A1D832C2BBBDE | Rating Details |
| 2023-03-06 08:06:47 -0600 | FD89EFB54BF22A6038EFA17EB32EA5B7D16091743F333AEDBD3DCD657161FDC2 | Rating Details |
| 2023-03-07 10:27:22 -0600 | Rating Details | |
| 2023-03-07 02:55:26 -0600 | Rating Details | |
| 2023-03-07 01:02:12 -0600 | Rating Details | |
| 2023-03-06 09:23:07 -0600 | Rating Details | |
| 2023-03-06 07:22:24 -0600 | Rating Details | |
| 2023-03-06 07:16:17 -0600 | Rating Details | |
| 2023-03-21 14:38:17 -0500 | Rating Details | |
| 2023-03-06 12:02:35 -0600 | Rating Details | |
| 2023-03-06 10:41:36 -0600 | Rating Details | |
| 2023-03-06 07:45:14 -0600 | Rating Details | |
| 2023-03-06 13:19:38 -0600 | Rating Details | |
| 2023-03-06 05:21:20 -0600 | Rating Details | |
| 2023-03-21 14:38:17 -0500 | Rating Details | |
| 2023-03-06 13:30:07 -0600 | Rating Details | |
| 2023-03-06 08:06:47 -0600 | Rating Details | |
| 2023-03-06 14:37:37 -0600 | Rating Details | |
| 2023-03-06 04:40:04 -0600 | Rating Details | |
| 2023-03-06 12:02:35 -0600 | Rating Details | |
| 2023-03-06 07:28:15 -0600 | Rating Details | |
| 2023-03-07 12:17:09 -0600 | Rating Details | |
| 2023-03-05 21:17:52 -0600 | Rating Details | |
| 2023-03-06 07:22:24 -0600 | Rating Details | |
| 2023-03-07 08:35:58 -0600 | Rating Details | |
| 2023-03-06 09:23:07 -0600 | Rating Details | |
| 2023-03-05 21:10:34 -0600 | Rating Details | |
| 2023-03-06 11:34:23 -0600 | Rating Details | |
| 2023-03-05 21:55:23 -0600 | Rating Details | |
| 2023-03-06 13:03:58 -0600 | Rating Details | |
| 2023-03-06 13:56:13 -0600 | Rating Details | |
| 2023-03-06 13:08:37 -0600 | Rating Details | |
| 2023-03-06 09:10:09 -0600 | Rating Details | |
| 2023-03-06 19:04:52 -0600 | Rating Details | |
| 2023-03-06 14:27:48 -0600 | Rating Details | |
| 2023-03-05 21:29:12 -0600 | Rating Details | |
| 2023-03-06 15:40:34 -0600 | Rating Details | |
| 2023-03-05 22:51:22 -0600 | Rating Details | |
| 2023-03-06 10:41:36 -0600 | Rating Details | |
| 2023-03-06 13:43:33 -0600 | Rating Details | |
| 2023-03-06 12:55:26 -0600 | Rating Details | |
| 2023-03-06 15:23:09 -0600 | Rating Details | |
| 2023-03-05 20:56:42 -0600 | Rating Details | |
| 2023-03-06 10:21:00 -0600 | Rating Details | |
| 2023-03-07 10:27:22 -0600 | Rating Details | |
| 2023-03-08 14:25:05 -0600 | Rating Details | |
| 2023-03-06 05:27:54 -0600 | Rating Details | |
| 2023-03-06 07:38:33 -0600 | Rating Details | |
| 2023-03-06 14:28:26 -0600 | Rating Details | |
| 2023-03-06 10:32:05 -0600 | Rating Details | |
| 2023-03-06 17:14:43 -0600 | Rating Details | |
| 2023-03-07 08:06:58 -0600 | Rating Details | |
| 2023-03-06 06:23:37 -0600 | Rating Details | |
| 2023-03-07 02:55:26 -0600 | Rating Details | |
| 2023-03-06 13:08:38 -0600 | Rating Details | |
| 2023-03-07 13:24:44 -0600 | Rating Details | |
| 2023-03-06 21:58:21 -0600 | Rating Details | |
| 2023-03-06 08:08:56 -0600 | Rating Details | |
| 2023-03-06 13:05:48 -0600 | Rating Details | |
| 2023-03-06 04:28:16 -0600 | Rating Details | |
| 2023-03-06 10:33:42 -0600 | Rating Details | |
| 2023-03-07 01:02:12 -0600 | Rating Details | |
| 2023-03-06 07:45:14 -0600 | Rating Details | |
| 2023-03-06 07:16:17 -0600 | Rating Details | |
| 2023-03-07 15:07:59 -0600 | Rating Details | |
| 2023-03-07 18:35:25 -0600 | Rating Details | |
| 2023-03-06 04:34:21 -0600 | Rating Details | |
| 2023-03-06 13:12:50 -0600 | Rating Details |